Biomatrix Healthcare Private Limited Ornidazole Export Data — India (DGFT 2022–2026)

Name: Biomatrix Healthcare Private Limited Ornidazole Export Records India — #5 Exporter, 22 Shipments, $257.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ornidazole

India Pharmaceutical Trade Intelligence

$17.7M249 Suppliers83 CountriesHS 30049099

ExportsIndia → TANZANIA28.1%India → FRANCE19.7%

Biomatrix Healthcare Private Limited — Ornidazole Exporter #5 | $257.4K Trade Value | TransData Nexus | TransData Nexus

Biomatrix Healthcare Private Limited — Ornidazole Exporter Profile

Indian Pharmaceutical Exporter · #5 for Ornidazole · $257.4K export value · DGFT Verified

Biomatrix Healthcare Private Limited is the #5 Indian exporter of Ornidazole with $257.4K in export value and 22 verified shipments. Biomatrix Healthcare Private Limited holds a 1.5% market share in Ornidazole exports across 4 countries. The company exports 15 pharmaceutical products worth $25.7M across 6 therapeutic categories.

Biomatrix Healthcare Private Limited — Ornidazole Export Profile: Buyers & Destinations

Biomatrix Healthcare Private Limited Ornidazole export treemap — buyers and destination countries | TransData Nexus

Where Does Biomatrix Healthcare Private Limited Export Ornidazole?

Country	Value	Shipments	Share
CONGO	$99.3K	4	33.9%
ANGOLA	$66.6K	9	22.7%
CONGO D REPULIC	$65.3K	5	22.3%
CONGO, THE DEMOCRATIC REPUBLIC OF THE	$51.8K	5	17.7%
TANZANIA	$9.9K

Who Are the Top Buyers of Ornidazole from Biomatrix Healthcare Private Limited?

Buyer	Country	Value	Orders
UNIQUE PHARMA,	CONGO, THE DEMOCRATIC REPUBLIC OF THE	$104.3K	9
UNIQUE PHARMA	CONGO	$84.0K	4
UNICA FARMA, LDA.	ANGOLA	$40.0K	5
UNIQUE PHARMA STE UNION DE	TANZANIA	$38.0K	3
UNICA FARMA LDA ESTRADA DIREITA DE	ANGOLA	$16.8K	1
UNICA FARMA,LDA.	ANGOLA	$9.8K	3

Biomatrix Healthcare Private Limited supplies Ornidazole to 6 buyers globally. The largest buyer is UNIQUE PHARMA, (CONGO, THE DEMOCRATIC REPUBLIC OF THE), followed by UNIQUE PHARMA (CONGO) and UNICA FARMA, LDA. (ANGOLA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ornidazole Formulations Does Biomatrix Healthcare Private Limited Export?

Product Description / Formulation	Value	Shipments
Ofloxacin & Ornidazole Infusion OFLOQ-O	$50.0K	1
OFLOXACIN AND ORNIDAZOLE INFUSION (0.2 % W/V + 0.5 % W/V) (OFLOQ OZ INFUSION)EACH 100 ML CONTAINS: (AS PER INV)	$30.6K	1
Ofloxacin & Ornidazole Infusion OFLOQUE-OZ Each 100 ml contains AS PER INV	$28.7K	1
Ofloxacin And Ornidazole Infusion (0.2 %w/v + 0.5 % w/v) (Ofloq OZ) (AS PER INV)	$27.4K	2
Ofloxacin & Ornidazole Infusion (OFLOQUE	$16.9K	1
OFLOXACIN AND ORNIDAZOLE INFUSION 0.2 % W/V + 0.5 % W/V OFLOQ OZ INFUSION AS PER INV	$16.8K	1
OFLOXACIN AND ORNIDAZOLE INFUSION (0.2 %W/V + 0.5 % W/V) (OFLOQ OZ). ( PACK : 100 ML ) ( AS PER INV )	$16.5K	1
Ofloxacin Ornidazole Infusion OFLOQ OZ	$16.2K	1
Ofloxacin & Ornidazole Infusion (Ofloque-OZ) (AS PER INV)	$13.9K	1
ORNIDAZOLE INFUSION (0.5 % W/V) (OZ INFUSION) (AS PER INV)	$13.0K	1

Biomatrix Healthcare Private Limited exports 19 distinct Ornidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Ofloxacin & Ornidazole Infusion OFLOQ-O with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Biomatrix Healthcare Private Limited Compare to Nearest Ornidazole Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	LINCOLN PHARMACEUTICALS LTD	$700.0K	14	5	$50.0K
4	KUSUM HEALTHCARE PRIVATE LIMITED	$504.7K	49	11	$10.3K
5	BIOMATRIX HEALTHCARE PRIVATE LIMITED ★	$257.4K	22	4	$11.7K
6	CACHET PHARMACEUTICALS PRIVATE LIMITED	$252.6K	42	7	$6.0K
7	AURA PHARMACEUTICALS PRIVATE LIMITED	$222.1K	14	5	$15.9K

Biomatrix Healthcare Private Limited ranks #5 among 249 Indian Ornidazole exporters. Average shipment value of $11.7K compared to the market average of $35.6K. The closest competitors by value are LINCOLN PHARMACEUTICALS LTD and KUSUM HEALTHCARE PRIVATE LIMITED.

Which Indian Ports Ship Ornidazole Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	118	10.0%
JNPT/ NHAVA SHEVA SEA	77	6.6%
DELHI AIR CARGO ACC (INDEL4)	75	6.4%
DELHI AIR	69	5.9%
SAHAR AIR CARGO ACC (INBOM4)	66	5.6%
SAHAR AIR	60	5.1%
JNPT	58	4.9%
BANGALORE ACC (INBLR4)	53	4.5%

Geopolitical & Trade Policy Impact on Biomatrix Healthcare Private Limited's Ornidazole Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Biomatrix. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight charges and extended transit times. These logistical hurdles can delay deliveries and escalate costs, particularly affecting time-sensitive pharmaceutical shipments. (pharmaceuticalcommerce.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, recent U.S. tariffs on imports from countries including India pose a significant challenge. These tariffs, reaching up to 50%, could impact nearly 55% of India's exports to the U.S., placing companies like Biomatrix at a competitive disadvantage due to increased costs. (apnews.com)

In the European Union, stringent regulatory frameworks such as the Falsified Medicines Directive necessitate compliance with rigorous safety and quality standards. For Biomatrix, obtaining European Market Authorization for products like Sitagliptin Tablets signifies a proactive approach to meeting these requirements, thereby facilitating smoother access to the EU market. (biomatrixhealthcare.com)

Biomatrix Healthcare Private Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened scrutiny regarding quality and compliance. India, housing over 600 US FDA-approved manufacturing sites, faces challenges in maintaining consistent quality standards. The US FDA's increased inspections, exceeding 200 in 2023 with plans for more in 2024, underscore the critical importance of compliance. (fact.net.in)

For Biomatrix, securing approvals from regulatory bodies such as the FDA Philippines and the Iraqi Ministry of Health reflects a commitment to upholding international quality standards. These achievements not only enhance the company's reputation but also serve as a competitive advantage in the global market. (biomatrixhealthcare.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ornidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Biomatrix Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 25 individual customs records matching Biomatrix Healthcare Private Limited exporting Ornidazole, covering 19 formulations to 5 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 83+ countries, 439+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ornidazole

Ornidazole

Biomatrix Healthcare Private Limited — Ornidazole Exporter Profile

Biomatrix Healthcare Private Limited — Ornidazole Export Profile: Buyers & Destinations

Where Does Biomatrix Healthcare Private Limited Export Ornidazole?

Who Are the Top Buyers of Ornidazole from Biomatrix Healthcare Private Limited?

What Is India's Total Ornidazole Export Value and How Much Does Biomatrix Healthcare Private Limited Contribute?

What Is the Average Shipment Value for Biomatrix Healthcare Private Limited's Ornidazole Exports?

How Does Biomatrix Healthcare Private Limited Compare to Other Indian Ornidazole Exporters?

What Ornidazole Formulations Does Biomatrix Healthcare Private Limited Export?

How Does Biomatrix Healthcare Private Limited Compare to Nearest Ornidazole Exporters?

Which Indian Ports Ship Ornidazole Exports?

What Other Advanced Antibiotics Products Does Biomatrix Healthcare Private Limited Export?

Geopolitical & Trade Policy Impact on Biomatrix Healthcare Private Limited's Ornidazole Exports

Biomatrix Healthcare Private Limited — Regulatory Compliance & Quality Standards

About Biomatrix Healthcare Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ornidazole Export Data from Biomatrix Healthcare Private Limited

Ornidazole Stats

Company Overview

Top Products by Biomatrix Healthcare Private Limited

Related Analysis

Need Detailed Export Data?

Data Source